Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression.
- Author:
Yi Cheng HOU
1
;
Chien Han LAI
Author Information
1. Department of Nutrition, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taipei City, Taiwan.
- Publication Type:Case Report
- Keywords:
Tardive dyskinesia;
Quetiapine;
Psychotic depression
- MeSH:
Antipsychotic Agents;
Brain;
Clozapine;
Depression*;
Electroencephalography;
Humans;
Magnetic Resonance Imaging;
Movement Disorders*;
Neurologic Examination;
Receptors, Dopamine D2;
Quetiapine Fumarate
- From:Clinical Psychopharmacology and Neuroscience
2014;12(2):163-165
- CountryRepublic of Korea
- Language:English
-
Abstract:
The atypical antipsychotics were believed to induce less extrapyramidal syndrome, including tardive dyskinesia (TD). Since the introduction of the quetiapine, it is also reported with less TD side effects. It even can relieve the symptoms of severe TD and reduce the risk of TD. The quetiapine's low affinity and fast dissociation from postsynaptic dopamine D2 receptors should give the least risk of producing the symptoms of TD. The quetiapine even can reduce the TD side effects related to clozapine, which has the lowest risk for TD. However, since the first case report of TD side effects related to quetiapine published on 1999, the safety of quetiapine in TD aspect has been questioned. Therefore, we want to share this case report, which was written to describe the severe late-onset TD side effects after long-term use of quetiapine in a patient with psychotic depression. The patient had no significant findings after concurrent comprehensive neurological examinations, magnetic resonance imaging of brain and electroencephalogram since the onset of TD.
